You are here

TROPHOGEN INC

Company Information
Address
9714 MEDICAL CENTER DR
ROCKVILLE, MD 20850-3343
United States


http://www.trophogen.com

Information

UEI: JSYSU447VRP3

# of Employees: 5


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Novel Recombinant High-Affinity, Long- and Dual-Acting Equine CG Analogs for Improved and More EthicalReproduction in Pigs and Cattle

    Amount: $1,460,767.00

    The current proposal of the PI’s second veterinary product, the first more potent and long acting recombinant equine chorionic gonadotropin (reCG) agonist for improved and, for the first time, total ...

    SBIRPhase II2019Department of Health and Human Services National Institutes of Health
  2. Novel Long Acting rhTSH Superagonist Analogs for Improved Diagnostic Imaging, Thyroglobulin Stimulation and Therapy of Thyroid Cancer.

    Amount: $1,557,540.00

    Thyroid cancer is the most common malignancy of endocrine tissues, disproportionally affecting women, and is one of the few cancers greatly increasing in incidence andamp; prevalence for unknown reaso ...

    SBIRPhase II2019Department of Health and Human Services National Institutes of Health
  3. Novel Long Acting rhTSH Superagonist Analogs for Improved Diagnostic Imaging, Thyroglobulin Stimulation and Therapy of Thyroid Cancer.

    Amount: $285,070.00

    PROJECT SUMMARYABSTRACT Thyroid cancer is the most common malignancy of endocrine tissuesdisproportionally affecting womenand is one of the few cancers greatly increasing in incidence andampprevalence ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
  4. Development of Novel and Affordable Neoglycosylated, Long Acting Superactive Analog of Human FSH for Infertility

    Amount: $1,768,121.00

    PROJECT SUMMARY ABSTRACT It is estimated that overof all American couples suffer from infertilitya topic of great importance to NICHD and cited frequently by this InstituteProfessional American women ...

    SBIRPhase II2018Department of Health and Human Services National Institutes of Health
  5. Development of Novel and Affordable Neoglycosylated Long Acting Superactive Analog of Human FSH for Infertility

    Amount: $299,999.00

    PROJECT SUMMARY ABSTRACT It is estimated that over of all American couples suffer from infertility a topic of great importance to NICHD and cited frequently by this Institute Professional Americ ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  6. Novel Recombinant High Affinity Long and Dual Acting Equine CG Analogs for Improved and More Ethical Reproduction in Pigs and Cattle

    Amount: $138,880.00

    As their first application for veterinary health the two PI s have already remarkably employed their novel patented superagonist and neoglycosylation technology to develop the first recombinant muc ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  7. Novel High Affinity VEGF Analogs For Targeted Imaging of Thyroid Cancer

    Amount: $1,590,836.00

    DESCRIPTION provided by applicant Thyroid cancer of follicular origin is the most common malignancy of endocrine tissues disproportionally affecting women and is one of the few cancers greatly in ...

    SBIRPhase II2014Department of Health and Human Services National Institutes of Health
  8. Novel High Affinity VEGF Analogs for Imaging Thyroid Cancer

    Amount: $283,958.00

    DESCRIPTION (provided by applicant): Thyroid cancer of follicular origin is the most common malignancy of endocrine tissues, disproportionally affecting women, and is one of the few cancers greatly in ...

    SBIRPhase I2013Department of Health and Human Services National Institutes of Health
  9. Novel High Affinity and Long-Acting Bovine FSH Analogs for Veterinary Superovulat

    Amount: $150,000.00

    DESCRIPTION (provided by applicant): Bovine ovarian superovulation is the current state-of-the-art method employed worldwide to maintain and improve milk and beef production through genetic selection ...

    SBIRPhase I2012Department of Health and Human Services Food and Drug Administration
  10. Development of Superactive Analogs of FSH for Human Infertility

    Amount: $2,931,156.00

    DESCRIPTION (provided by applicant): Infertility affects about 10% of American couples, and there is a very large and rapidly growing market for therapeutics in this field, particularly the primary ho ...

    SBIRPhase II2011Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government